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Abstract
Background: A femoral neck fracture (FNF) is a common cause of suffering and premature death in the elderly
population. Optimizing the treatment for improved outcome and a reduced need for secondary surgery is
important both for the patient and the society. The choice of primary total or hemiarthroplasty in patients over
eighty years are controversial. We hypothesized that total hip arthroplasty has an equal or better outcome in
patient-reported outcome compared with hemiarthroplasty.
Methods/Design: A prospective, randomized, single-blinded trial will be conducted. We will include 120 patients,
80 years of age and over with an acute (<36 h) displaced femoral neck fracture. The patients will be randomized in
a 1:1 ratio to either total hip arthroplasty or hemiarthroplasty. The primary endpoints are Harris hip Score and EQ-
5D. Secondary endpoints include pain measured with visual analogue scale, surgical time, reoperations,
complications and radiological measurement of erosion in patients operated with hemiarthroplasty. Follow-up will
be performed postoperatively after three months, 1, 2, 4 and 10 years.
Discussion: To our knowledge, this is the first randomized controlled trial comparing total hip arthroplasty and
hemiarthroplasty for displaced femoral neck fracture in patients age 80 years and over.
Trial registration: Clinicaltrial.gov: NCT02246335
Keywords: Femoral neck fracture, Hemiarthroplasty, Total hip arthroplasty, Harris hip score, Randomized clinical trial,
Octagenerians
Background
How femoral neck fractures in aged patients should be
treated are determined by the degree of displacement,
age, functional demands, surgeon preference and risk for
complications associated with cognitive function and
degree of physical fitness [1–7]. The main methods of
choices are internal fixation, hemiarthroplasty and total
hip arthroplasty. Internal fixation is the main alternative
for young patients with displaced intracapsular fractures
and in frailest elderly patients who are not medically fit
for prosthesis surgery [2, 8]. Most surgeons seem to rec-
ommend that hemiarthroplasty is the preferred treatment
for elderly patients with low functional demands in the
absence of arthritic changes in the hip [9]. However, des-
pite extensive research during the last decades and a
number of randomized controlled studies that has been
published comparing the types of arthroplasty in the
treatment of displaced femoral neck fractures - the ques-
tion remains if there is any advantage in replacing the
healthy acetabulum with a prosthetic cup in the healthy,
cognitive intact elderly patient [10–15]. A number of pub-
lished studies have suggested that total hip arthroplasty
may produce better hip patient reported outcomes com-
pared with hemiarthroplasty. However, the majority of
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studies conducted are made for a subgroup of patients
that are active and living in their own homes without cog-
nitive alteration. The study settings are, with few excep-
tions [12, 14, 15], made up of a relative large population
of patients below 80 years of age. Nevertheless, even a pa-
tient with low demands seems to benefit from a total hip
arthroplasty. Reported advantages of hemiarthroplasty
over total hip arthroplasty are a reduced rate of disloca-
tion, shorter operation times including less blood loss
and less technically demanding surgery [14-17]. Sur-
geons favouring total hip arthroplasty rely on the ten-
dency for improved hip function. The longevity and
level of activity of todays elderly increases the risk for
protrusion of the femoral head in the acetabulum and
the need for revision operation. Despite the more exten-
sive surgery during total hip arthroplasty there has not
been any detectible difference in mortality in compari-
son to hemiarthroplasty [1, 18].
We hypothesized that a total hip arthroplasty results
in superior hip function and health-related quality of life
compared to to hemiarthroplasty in healthy and cogni-
tively intact patients aged above 80 years treated for a
displaced femoral neck fracture. The secondary outcome




A randomized controlled trial will be conducted. The
study will be carried out from 2009–2026 (inclusion
period 2009–2016) at the Orthopaedic Department of
Danderyd Hospital in collaboration with the Karolinska
Institute. The study will be conducted in accordance
with the ethical principles of the Declaration of
Helsinki. The Ethics Committee of the Karolinska Insti-
tute approved the study. The trial is initiated, designed,
Fig. 1 Flow diagram
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and performed as an academic investigation and regis-
tered at ClinicalTrials.gov (number NCT02246335).
The guidelines of the CONSORT Statement will be
followed [19].
Study population
All patients with a femoral neck fracture who are admit-
ted to Danderyd Hospital during the inclusion period
will be screened for participation in the study and those
who agree to participate and provide written informed
consent will be included. The inclusion criteria are an
acute displaced femoral neck fracture (Garden stage
III or IV) that had been sustained within the previous
thirty-six hours, an age of eighty years or more [20],
an ability to walk indoors and outdoors with or with-
out the help of walking aids and an absence of cogni-
tive dysfunction (Pfeiffer test 8–10 points) [21].
Exclusion criteria includes patients with osteoarthritis
or rheumatoid arthritis in the fractured hip, patho-
logic fractures, non-walkers, severe cognitive impair-
ment (Pfeiffer test 0–7), and contraindications for
surgery by other reasons (ulcers, severe somatic ill-
ness, severe bleeding disorder) and those who were
unsuitable to participate in the trial for any other rea-
son (i.e. psychiatric disease, alcoholism).
A detailed inclusion and exclusion list is presented in
Table 1. The inclusion period is planned from 2009–2016.
End of study (EOS) will be at the last included patient’s
last visit in 2026 (Fig. 1, Table 2).
Treatments
Half of the patients will receive a cemented hemiarthro-
plasty with a modular unipolar head. The other half will
receive a cemented total hip arthroplasty with a 32-mm
femoral head articulating on a cemented highly cross-
linked polyethylene acetabular component. The same
stem and the same bone cement will be used for both
groups. The operations will be performed either by a
consultant orthopedic surgeon or by a registrar with as-
sistance from a consultant. A direct lateral approach will
be used [22]. The direct lateral approach is performed
through a midline incision over the greater trochanter
through the subcutaneous fat and the fascia. The anterior
one-third of the gluteus medius insertion and gluteus
minimus insertion on the tip of greater trochanter are de-
tached. Excision of the anterior hip joint capsule is per-
formed from the base to the acetabulum. The fractured
femoral neck is planed and the caput femoris is ex-
tracted. During closure of the wound, the detached
part of muscle gluteus medius and minimus is re-
attached to the trochanter. Prophylactic cloxacillin is
administered 30 min before surgery, and the cloxacil-
lin also another 3 times over 24 h postoperatively.
Low-molecular weight heparin will be administered
for 30 days postoperatively. The patients are mobi-
lized according to a standard physiotherapy program,
and full weight bearing with the use of crutches are
encouraged. Plain x-rays of the pelvis and hip will be
taken postoperatively and at follow-up.
Randomization and blinding
Patients will be randomized in a 1:1 ratio to hemiar-
throplasty or total hip arthroplasty using concealed
envelopes in batch sizes of 10. Randomization will be
stratified for gender and patients will be blinded for
the assigned treatment during the first two years of
follow-up. Patients will not be allowed to view x-rays.
Ward staff and physiotherapists are aware of alloca-
tions but are mindful that patients are blinded and
are encouraged not to speak to patients about alloca-
tion. The physiotherapy, nor any other in-hospital
care, do not differ between the two groups. In
addition, the blinding will be controlled for at the 1
and 2 year follow-up where patients will be asked
what group they think they belong to. The blinding is
ended at the 2-year follow-up and in case of any hip
related serious adverse events such as reoperations
for any reasons.
When and how to withdraw subjects from the trial
Should a subject request or decide to withdraw from
the study, all efforts will be made to complete and re-
port the observations as thoroughly as possible up to
the date of withdrawal. For withdrawn subjects the last
post-baseline observation will be carried forward. In a
case of withdrawal of full consent, the subject will be
followed according to the routine standard follow-up of
arthroplasty patients at our institution, including
Table 1 Detailed inclusion and exclusion criteria
Inclusion criteria
1. Age above 80 years.
2. Acute (<36 h) displaced femoral neck fracture (Garden ≥3).
3. Independent walking ability with or without walking aids.
4. Pfeiffer test 8–10 points.
Exclusion criteria
1. Osteoarthritis or rheumatoid arthritis in the fractured hip
2. Pathologic fractures
3. Non-walkers
4. Cognitive impairment (Pfeiffer Test 0–7)
5. Contraindications for surgery by other reasons (ulcers,
severe somatic illness, severe bleeding disorder).
6. Unsuitable to participate in the trial for any other reason.
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regular clinical examinations and radiographic follow-
up visit at the operating surgeon every 2–3 years.
Endpoints and follow-up
The primary endpoint variable will be patient-reported
functional hip status assessed with Harris hip score [23–
25] and health related health-related quality of life
assessed by the EQ-5D (EuroQoL) at 2 years. EQ-5D
uses five dimensions: mobility, self-care, usual activity,
pain/discomfort and anxiety/depression [26].
Secondary endpoints include functional scores at the
other follow-up times and pain in the operated hip eval-
uated with VAS (Visual Analogue Scale [27], surgical
time and blood loss, erosion of the acetabular cartilage
in patients treated with hemiarthroplasty (evaluated ac-
cording to Baker et al. [11]).
The study period is 10 years. Follow-up will be per-
formed at 3 months, 1, 2, 4, 6 and 10 years. First study
results will be reported after the last patient enrolled in
the study has been followed for 2 years.
Data quality assurance
The study progress and study conduct will be moni-
tored before, during and after the study to ensure
that ICH-GCP, regulatory requirements, and all as-
pects of the protocol are followed. A digital case re-
port form (CRF) will be used throughout the study.
The medical records and other documents will be
reviewed for verification of agreement with data on
the CRF. The subject has a right for a protection
against invasion of privacy. In this study, each subject
will receive a unique identification number, which will
be linked to the CRF. The data will then be blinded
correspondingly in all data analyses. However, the
study monitor, auditor, representative from any regu-
latory authority, as well as the appropriate Ethical
Committee are permitted to review the subject’s pri-
mary medical records including laboratory test result
reports, ECG reports, admission and discharge sum-
maries, AE and SAE reports occurring during the
study.
Sample size
Prior to the commencement of the study, a two-sided
power analysis has been performed. We will test the
null hypothesis that the mean Harris hip scores for
the two groups will be equal. We assume that a mean
difference of 10 points (standard deviation, 15
points) [4] in the Harris hip score is the smallest ef-
fect that will be clinically relevant. We calculate that
a total of 80 patients (40 in each group) will have a
power of 80 % to yield a significant result.
This calculation also allows a 80 % power to prove
non-inferiority (non- difference) of the secondary end-
point EQ-5D with a sample of 40 patients in each group
with the assumption of an EQ-5D value of 0.73 with
standard deviation 0:18. The significance level was set at
a conservative 2.5 % (p <0.025) because we have two
sample size calculations. We will include 60 patients in
each group (120 total) to allow for loss to follow-up.
Statistics
The analyses will be performed on the basis of the
intention-to-treat principle, and all patients who are al-
located to either group will be included in the analysis,
regardless of actual surgery performed. Descriptive sta-
tistics (means and standard deviations) will be used to
describe the patient characteristics and outcome vari-
ables at the measurement points. We will use the Stu-
dent’s t-test and Levene’s test for comparison of Harris
hips score and EQ-5D between the groups. An analysis
of covariance (ANCOVA) of the primary endpoint will
also be used to reduce variance, adjusted for exposure
variable (total hip arthroplasty/hemiarthroplasty) and
stratification (male/female). For subjects that withdrawn
from the study before completion, the data from the last
observation will be carried forward (imputed). The ana-
lyses will be performed with SPSS 22.0 for Windows
(SPSS, Chicago, Illinois) statistical software.
Discussion
Rationale for the study
Whether to choose hemiarthroplasty or total hip
arthroplasty in the treatment of displaced femoral
neck fractures in the most elderly and fit patients are
often debated. Despite indications that total hip
arthroplasty yields a better patient reported outcome,
it is plagued with an increased risk for prosthetic dis-
location and thus revision surgery in patients with
cognitive impairment. The frequency of patients with
manifest or impending cognitive impairment increases
with age and thus the risk for complications. The
previously published studies in the field have a het-
erogeneity across the included selection of patients
and distinct subgroup effects [18]. There is a lack of
Table 2 Secondary endpoints
No. Measurement Follow-up time
1 Baseline data including height, weight,
medical history, physical examination
Screening
2. Pain Numerical Rating Scale (PNRS) Screening, 3 months,
1, 2, 4, 6 and 10 years
3. Complications Screening, 3 months,
1, 2, 4, 6 and 10 years
4 Reoperations Screening, 3 months,
1, 2, 4, 6 and 10 years
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level one evidence regarding the choice of arthro-
plasty in the fit most elderly patients.
Study design
The internal validity of this trial is good due to the strict
inclusion criteria, recruitment procedure and rigorous
follow-up. However, some difficulties regarding blinding
must be mentioned. Postoperative X-rays will reveal the
type of allocation for the investigators. However, patients
are blinded to their treatment and thus would not affect
the patient reported outcome.
The exclusion criteria can affect the external validity
and generalizability due to the fact that a large number
of patients will be excluded from the trial. However, the
exclusion criteria are mainly focusing on excluding
patients with either a malignant disease or those with
contraindications for either treatment methods.
We have chosen the primary end-point to be evaluated
at several follow-up periods postoperatively, to be able
to detect differences in rehabilitation and during short
to medium term. We expect that the effect of acetabular
erosion may influence the results of hemiarthroplasty at
follow-up after the 1 year follow-up.
Patient reported outcome measurements
The trial’s main outcome measurements are Harris hip
score and EQ-5D. Both of these are valid measurements
and has been used in an number of hip fracture trials.
Although Harris hip score has been questioned due to
ceiling effect and may be inferior to WOMAC and
HOOS as a disease specific questinnaire, this has not
been confirmed in the hip fracture population [28–30].
The use of HHS also makes comparisons to other trials
easier and it has been validated for the use in patients
with a femoral neck fracture [30].
Conclusion
The present trial will provide evidence for the future
choice of arthroplasty in elderly patients above the age
of 80 years with a displaced femoral neck fracture and
without cognitive impairment.
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